Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1,404,321
-
Shares change
-
-15,188
-
Total reported value, excl. options
-
$3,861,965
-
Value change
-
-$42,264
-
Put/Call ratio
-
567%
-
Number of buys
-
5
-
Number of sells
-
-11
-
Price
-
$2.75
Significant Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q2 2024
25 filings reported holding ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q2 2024.
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,404,321 shares
of 66,587,586 outstanding shares and own 2.11% of the company stock.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (634,033 shares), VANGUARD GROUP INC (205,753 shares), GEODE CAPITAL MANAGEMENT, LLC (106,489 shares), EDGEWOOD MANAGEMENT LLC (100,000 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (90,382 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (64,012 shares), RENAISSANCE TECHNOLOGIES LLC (48,196 shares), STATE STREET CORP (40,300 shares), SeaCrest Wealth Management, LLC (34,954 shares), and BlackRock Inc. (22,921 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.